RGNX - REGENXBIO Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending2018-12-312017-12-312016-12-312015-12-31
Current Assets
Cash And Cash Equivalents75,56146,65624,84054,116
Short Term Investments244,200114,12264,71460,025
Net Receivables9,3374731,0322,136
Inventory----
Other Current Assets3,0811,4121,010851
Total Current Assets337,913167,99793,371118,148
Long Term Investments151,21916,01669,412102,526
Property Plant and Equipment28,70213,9779,324538
Goodwill----
Intangible Assets----
Accumulated Amortization----
Other Assets25,980687625168
Deferred Long Term Asset Charges----
Total Assets543,814198,677172,732221,380
Current Liabilities
Accounts Payable4,4124,8321,5431,014
Short/Current Long Term Debt----
Other Current Liabilities3,164430844127
Total Current Liabilities22,17614,4379,6694,339
Long Term Debt----
Other Liabilities6,9361,2111,326233
Deferred Long Term Liability Charges----
Minority Interest----
Negative Goodwill----
Total Liabilities34,96615,64810,9954,572
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock4333
Retained Earnings-83,016-187,756-114,587-51,620
Treasury Stock-720-715-33-719
Capital Surplus592,580371,497276,354269,144
Other Stockholder Equity-720-715-33-719
Total Stockholder Equity508,848183,029161,737216,808
Net Tangible Assets508,848183,029161,737216,808